GGrantIndex
← Leaderboards

Kristina M Adams Waldorf

University Of Washington

Google Scholar ↗PubMed ↗ORCID ↗
$20,913,441
Attributed
$32,515,163
Total exposure
19
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.6M · FY2007–25
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$32,515,163 · 19

By mechanism

R01$28,684,857 · 8
P51$2,310,920 · 8
K08$631,530 · 1
R21$485,125 · 1
R38$402,731 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Nonhuman Primate”

Research focus

Nonhuman PrimateFetalInfectionPremature BirthPlacentaInjuryPregnancyPreventCellsImmune ResponsePathway InteractionsAmniotic FluidPathogenesisCytokinePregnantBacteriaSignal TransductionFetusInflammationAnimalsSamplingPathogenAnimal ModelImmune

Grant awards (52)

Impact of Zika Virus Infection on Fetal Innate and Adaptive Immunity$844,016
R01 · FY2025 · AI · contact PI
Influenza pathogenesis in pregnancy$833,919
R01 · FY2025 · AI · contact PI
IL-10 Delivery Using Extracellular Vesicles to Delay Preterm Birth$743,340
R01 · FY2025 · HD
Reproductive and Child Health StaRR Program$402,731
R38 · FY2025 · AI · contact PI
Impact of Zika Virus Infection on Fetal Innate and Adaptive Immunity$848,689
R01 · FY2024 · AI · contact PI
Influenza pathogenesis in pregnancy$843,733
R01 · FY2024 · AI · contact PI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$755,520
R01 · FY2024 · HD · contact PI
IL-10 Delivery Using Extracellular Vesicles to Delay Preterm Birth$635,254
R01 · FY2024 · HD
Immune Control of Group B Streptococcal Placental$880,047
R01 · FY2023 · AI
Influenza pathogenesis in pregnancy$857,164
R01 · FY2023 · AI · contact PI
JAK-STAT Control of Zika Virus-Induced Fetal Injury$807,987
R01 · FY2023 · AI · contact PI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$768,194
R01 · FY2023 · HD · contact PI
Immune Control of Group B Streptococcal Placental$891,373
R01 · FY2022 · AI
Influenza pathogenesis in pregnancy$849,396
R01 · FY2022 · AI · contact PI
JAK-STAT Control of Zika Virus-Induced Fetal Injury$840,095
R01 · FY2022 · AI · contact PI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$774,614
R01 · FY2022 · HD · contact PI
Role of the hyaluronidase in GBS Virulence$904,350
R01 · FY2021 · AI
Immune Control of Group B Streptococcal Placental$868,958
R01 · FY2021 · AI
JAK-STAT Control of Zika Virus-Induced Fetal Injury$864,353
R01 · FY2021 · AI · contact PI
Influenza pathogenesis in pregnancy$864,027
R01 · FY2021 · AI · contact PI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$770,043
R01 · FY2021 · HD · contact PI
JAK-STAT Control of Zika Virus-Induced Fetal Injury$328,382
R01 · FY2021 · AI · contact PI
Role of the hyaluronidase in GBS Virulence$904,628
R01 · FY2020 · AI
Immune Control of Group B Streptococcal Placental$891,718
R01 · FY2020 · AI
JAK-STAT Control of Zika Virus-Induced Fetal Injury$875,928
R01 · FY2020 · AI · contact PI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$775,145
R01 · FY2020 · HD · contact PI
Sofosbuvir Protection of the Fetal Brain from Zika Virus Infection in Pregnancy$220,625
R21 · FY2020 · AI · contact PI
JAK-STAT Control of Zika Virus-Induced Fetal Injury$919,950
R01 · FY2019 · AI · contact PI
Immune Control of Group B Streptococcal Placental$915,712
R01 · FY2019 · AI
Role of the hyaluronidase in GBS Virulence$904,628
R01 · FY2019 · AI
Sofosbuvir Protection of the Fetal Brain from Zika Virus Infection in Pregnancy$264,500
R21 · FY2019 · AI · contact PI
Role of the hyaluronidase in GBS Virulence$904,628
R01 · FY2018 · AI
Role of the hyaluronidase in GBS Virulence$912,767
R01 · FY2017 · AI
GBS mediated in utero fetal injury$741,923
R01 · FY2016 · AI
GBS mediated in utero fetal injury$759,395
R01 · FY2015 · AI
GBS mediated in utero fetal injury$771,648
R01 · FY2014 · AI
GBS mediated in utero fetal injury$78,195
R01 · FY2014 · AI
GBS mediated in utero fetal injury$740,566
R01 · FY2013 · AI
GBS mediated in utero fetal injury$814,572
R01 · FY2012 · AI
NONHUMAN PRIMATE MODEL OF STRETCH-INDUCED PRETERM LABOR$156,634
P51 · FY2011 · RR · contact PI
TOLL-LIKE RECEPTOR ANATAGONISM AS TREATMENT FOR PRETERM LABOR$156,634
P51 · FY2011 · RR · contact PI
Toll-Like Receptor Antagonism as a Potential Treatment for Preterm Labor$126,306
K08 · FY2011 · AI · contact PI
TOLL-LIKE RECEPTOR ANATAGONISM AS TREATMENT FOR PRETERM LABOR$310,163
P51 · FY2010 · RR · contact PI
EXPERIMENTAL MODEL FOR CHORIOAMNIIONITIS AND PRETERM LABOR$155,086
P51 · FY2010 · RR · contact PI
Toll-Like Receptor Antagonism as a Potential Treatment for Preterm Labor$126,306
K08 · FY2010 · AI · contact PI
TOLL-LIKE RECEPTOR ANATAGONISM AS TREATMENT FOR PRETERM LABOR$315,187
P51 · FY2009 · RR · contact PI
Toll-Like Receptor Antagonism as a Potential Treatment for Preterm Labor$126,306
K08 · FY2009 · AI · contact PI
TOLL-LIKE RECEPTOR ANATAGONISM AS TREATMENT FOR PRETERM LABOR$157,836
P51 · FY2008 · RR · contact PI
Toll-Like Receptor Antagonism as a Potential Treatment for Preterm Labor$126,306
K08 · FY2008 · AI · contact PI
OAR FUNDING FOR ENHANCEMENT OF FACILITIES FOR AIDS RELATED RESEARCH$954,733
P51 · FY2007 · RR · contact PI
Toll-Like Receptor Antagonism as a Potential Treatment for Preterm Labor$126,306
K08 · FY2007 · AI · contact PI
EXPERIMENTAL MODEL OF PRETERM LABOR$104,647
P51 · FY2007 · RR · contact PI